Fujimoto A - Search Results

1

Renal Function Improves After the Discontinuation of Androgen Deprivation Therapy in Japanese Patients With Prostate Cancer.

Masuda H, Fujimoto A, Kanesaka M, Hou K, Suyama T, Araki K, Kojima S, Naya Y. Masuda H, et al. Among authors: fujimoto a. Anticancer Res. 2021 Sep;41(9):4443-4446. doi: 10.21873/anticanres.15252. Epub 2021 Sep 1. Anticancer Res. 2021. PMID: 34475067

2

Usefulness of R.E.N.A.L Nephrometry Scoring System and Centrality Index Score for Predicting Outcome of Laparoscopic Partial Nephrectomy.

Sugiura M, Suyama T, Kanesaka M, Fujimoto A, Hou K, Araki K, Masuda H, Kojima S, Naya Y. Sugiura M, et al. Among authors: fujimoto a. J Laparoendosc Adv Surg Tech A. 2016 Oct;26(10):784-788. doi: 10.1089/lap.2016.0025. Epub 2016 Jul 19. J Laparoendosc Adv Surg Tech A. 2016. PMID: 27732324

3

PSA response following the 'steroid switch' in patients with castration-resistant prostate cancer treated with abiraterone: A case report.

Kato T, Kojima S, Fujimoto A, Otsuka K, Suyama T, Hou K, Araki K, Masuda H, Yamazaki K, Komiya A, Naya Y. Kato T, et al. Among authors: fujimoto a. Oncol Lett. 2018 Oct;16(4):5383-5388. doi: 10.3892/ol.2018.9321. Epub 2018 Aug 17. Oncol Lett. 2018. PMID: 30250608 Free PMC article.

4

Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel.

Ando K, Sakamoto S, Takeshita N, Fujimoto A, Maimaiti M, Saito S, Sanjyon P, Imamura Y, Sato N, Komiya A, Akakura K, Ichikawa T. Ando K, et al. Among authors: fujimoto a. Prostate. 2020 Feb;80(3):247-255. doi: 10.1002/pros.23938. Epub 2019 Dec 9. Prostate. 2020. PMID: 31816126

5

False-positive ¹²³I-metaiodobenzylguanidine scan in a patient with renal cell carcinoma: A case of chromophobe renal cell carcinoma oncocytic variant with a complicated clinical course.

Suyama T, Kanesaka M, Fujimoto A, Otsuka K, Hou K, Araki K, Masuda H, Kojima S, Yamazaki K, Naya Y. Suyama T, et al. Among authors: fujimoto a. IJU Case Rep. 2020 Oct 24;4(1):39-42. doi: 10.1002/iju5.12233. eCollection 2021 Jan. IJU Case Rep. 2020. PMID: 33426495 Free PMC article.

6

The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.

Maimaiti M, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Matsusaka K, Xu M, Ando K, Saito S, Wakai K, Imamura Y, Nakayama K, Kanai Y, Kaneda A, Ikehara Y, Ikeda JI, Anzai N, Ichikawa T. Maimaiti M, et al. Among authors: fujimoto a. Sci Rep. 2021 Jun 1;11(1):11478. doi: 10.1038/s41598-021-90748-9. Sci Rep. 2021. PMID: 34075107 Free PMC article.

7

Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.

Baba H, Sakamoto S, Zhao X, Yamada Y, Rii J, Fujimoto A, Kanesaka M, Takeuchi N, Sazuka T, Imamura Y, Akakura K, Ichikawa T. Baba H, et al. Among authors: fujimoto a. Cancers (Basel). 2022 Nov 25;14(23):5823. doi: 10.3390/cancers14235823. Cancers (Basel). 2022. PMID: 36497304 Free PMC article.

8

Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy.

Fukui Y, Yamada Y, Sakamoto S, Horikoshi T, Zhao X, Sato K, Nanba S, Kubota Y, Kanesaka M, Fujimoto A, Shibata H, Goto Y, Sazuka T, Imamura Y, Uno T, Ichikawa T. Fukui Y, et al. Among authors: fujimoto a. Anticancer Res. 2023 Dec;43(12):5705-5712. doi: 10.21873/anticanres.16776. Anticancer Res. 2023. PMID: 38030183

9

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy.

Sato H, Sazuka T, Fujimoto A, Kagitani S, Arai T, Goto Y, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. Sato H, et al. Among authors: fujimoto a. IJU Case Rep. 2023 Mar 19;6(3):185-189. doi: 10.1002/iju5.12584. eCollection 2023 May. IJU Case Rep. 2023. PMID: 37144081 Free PMC article.

10

A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types.

Tanaka S, Goto Y, Fujimoto A, Arai T, Sato H, Sazuka T, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. Tanaka S, et al. Among authors: fujimoto a. IJU Case Rep. 2023 Sep 4;6(6):410-414. doi: 10.1002/iju5.12636. eCollection 2023 Nov. IJU Case Rep. 2023. PMID: 37928302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

882 results

Search Page